Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Sees Large Decrease in Short Interest

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) was the recipient of a large drop in short interest in July. As of July 15th, there was short interest totalling 16,000 shares, a drop of 13.0% from the June 30th total of 18,400 shares. Based on an average trading volume of 2,600 shares, the days-to-cover ratio is presently 6.2 days.

Algernon Pharmaceuticals Stock Performance

AGNPF stock opened at $0.08 on Wednesday. The business has a fifty day moving average of $0.10 and a 200-day moving average of $0.08. Algernon Pharmaceuticals has a twelve month low of $0.04 and a twelve month high of $0.16.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.